Fig. 4From: In vivo degradation and neovascularization of silk fibroin implants monitored by multiple modes ultrasound for surgical applicationsSilk fibroin implants at the hind limb subcutaneous at day 0, 4, 8, 12, 16 and 18 (a–f) observed by 4D View softwareBack to article page